Abstract:Abstract 5α-reductase type 2 (5αR2) deficiency is an autosomal recessive inherited condition affecting 46,XY individuals resulting from the inability to convert testosterone into dihydrotestosterone. Affected individuals present a range of external genitalia undervirilization at birth and pronounced masculinization at puberty. Unlike most other 46,XY DSD, the frequency of gender change among 5αR2 deficiency is high. Objective to analyze the 451 individuals carrying pathogenic 5αR2 variants in the SRD5A2 gene in both alleles (in homozygous or compound heterozygous state) in the literature (Pubmed, EMBASE, Medline) and websites (ensemble, HGMD, ClinVar) regarding sex assignment, external genitalia virilization (1-5 Sinnecker score), and gender change accordingly country income Methods A total of 357 cases out of 451 had clinical information. All patients included were divided between those born before or after 2006 (the DSD consensus year). Country income was based on the 2018 World Bank classification, classifying income into four categories: low, lower-middle, upper-middle, and high (www.worldbank.org). Categorical variables were analyzed using the Chi-square test followed by the Cramer's V. Continuous variables were analyzed either by Student t-test or ANOVA one way. A binary logistic regression was built using sex assignment and gender change as categorical dependent variables. A p<.05 was considered significant. Results When we divided the individuals into those diagnosed after and before 2006, the percentage of female sex assignments dropped from 72% to 56% (p<.0001), followed by an odds ratio reduction (from 2.52 to 1.65) for female sex assignment. Country income did not impact sex assignment (p=.21). However, most cases (86%) were reported from countries with high and upper-middle economies. The absence of reports from low-income countries may be due to several reasons, such as barriers to molecular diagnosis, scientific access, and specialized medical assistance. Most cases were assigned as female (69%). The overall rate of gender change was 25% (89 out 357). All but one changed their gender from female to male. The rate of gender change was significantly different across all countries (V=0.46; p<.001), but it ranged from 16% to 70%, and gender change was lower among those diagnosed after 2006 (p=.01). The association between less external genitalia virilization and female sex assignment was significant (p<.001). On the other hand, the virilization score was similar between those who kept or changed gender (p=.37). Neither the type of SRD5A2 variant (missense, nonsense, indel) nor zygosity (homo/hetero) impacted sex assignment or gender change. Conclusion An apparent temporal trend indicates an increased likelihood of affected 5αR2 deficiency individuals being raised as boys, providing a gender change drop. The external virilization degree influenced sex assignment, but it does not affect gender change. There is no correlation between either both sex assignment and gender development with 5αR2 genetics. Presentation: Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.

SUN-362 Differences in Both Gonadal and Adrenal-Derived Androgens in 5α-Reductase Deficiency versus Androgen Insensitivity Syndrome and Normal Chinese Men Using LC-MS/MS

Differences of adrenal-derived androgens in 5 alpha-reductase deficiency versus androgen insensitivity syndrome

Growth Curves of Chinese Children with Androgen Insensitivity Syndrome: A Multicenter Registry Study

Recent advances in clinical management of androgen insensitive syndrome

Clinical, Hormonal, and Genetic Characteristics of 5a-Reductase Type 2 Deficiency in 103 Chinese Patients

Phenotypic and Molecular Characteristics in Eleven Chinese Patients with 5α‐reductase Type 2 Deficiency

Genetic Analysis of 25 Patients with 5Α-Reductase Deficiency in Chinese Population.

New Insights into 5Α-Reductase Type 2 Deficiency Based on a Multi-Centre Study: Regional Distribution and Genotype–phenotype Profiling Ofsrd5a2in 190 Chinese Patients

Clinical, Hormonal and Genetic Characteristics of Androgen Insensitivity Syndrome in 39 Chinese Patients

Circulating adrenal and gonadal steroid hormones heterogeneity in active young males and the contribution of 11-oxy androgens

Clinical and molecular characterization of 5α-reductase type 2 deficiency due to mutations (p.Q6X, p.R246Q) in SRD5A2 gene.

Identification of Three Novel SRD5A2 Mutations in Chinese Patients with 5Α-Reductase 2 Deficiency.

RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency

Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development

Clinical and Molecular Characteristics in 15 Patients with Androgen Receptor Gene Mutations from South China

The Correlation Between Phenotype and Genotype of 5Α-Reductase 2 Deficiency in 5 Children

The Analysis of Gene Mutation and Diagnosis and Treatment of 5Α-Reductase 2 Deficiency in a Child

Different Types of Androgen Receptor Mutations in Patients with Complete Androgen Insensitivity Syndrome.

Estradiol Concentrations in Young Healthy US Versus Chinese Men.

Clinical Characteristics, AR Gene Variants, and Functional Domains in 64 Patients with Androgen Insensitivity Syndrome

A chemiluminescence-based assessment of androgen-binding activity in a large pedigree affected with androgen insensitivity syndrome.